Trial Profile
Cost Effectiveness of Pemetrexed/Cisplatin (Pem/Cis) in the Treatment of Advanced, Non-Squamous, Non-Small Cell Lung Cancer (Nsqnsclc) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2012
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Oct 2012 New trial record
- 29 Sep 2012 Results presented at the 37th Congress of the European Society for Medical Oncology.